Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Wiener klinische Wochenschrift 13-14/2014

01.07.2014 | short report

Severe Clostridium difficile infection: incidence and risk factors at a tertiary care university hospital in Vienna, Austria

verfasst von: MD Peter Starzengruber, MD Luigi Segagni Lusignani, PhD Thomas Wrba, MD Dieter Mitteregger, MD Alexander Indra, MD Prof. Wolfgang Graninger, MD, MBA Elisabeth Presterl, MD Magda Diab-Elschahawi

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 13-14/2014

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

Background

Clostridium difficile infection (CDI) is the major cause of hospital-acquired bacterial diarrhoea. The incidence of CDI has been increasing in Canada, the US and Europe and severe cases are becoming more common.

Methods

A retrospective cohort study investigating all patients with an episode of CDI present at the Vienna University Hospital between 01 January 2012 and 31 December 2012 was conducted. All microbiologically confirmed C. difficile toxin positive cases were included, ribotyped and analysed regarding their clinical course.

Results

A total of 278 patients with CDI were recorded, with an overall CDI incidence of 5.23 per 10,000 patients-days. Around 84,5 % (235/278) of CDI cases would have been classified as severe CDI according to European Society of Clinical Microbiology and Infectious Diseases (ESCMID) if all criteria were used. According to Society for Healthcare Epidemiology of America and the Infectious Diseases Society of America (SHEA/IDSA) guidelines only 16.5 % (46/278) could be classified as severe; with a severe CDI incidence of 4.41 and 0.86 per 10,000 patient-days, respectively. Multivariate analysis showed only a co-morbidity index of ≥ 3 (p = 0.013) as independent risk factor for severe CDI. No link between ribotype 027 and severity or clustering was observed in our study population.

Conclusions

Special attention in terms of restrictive antibiotic prescription should be given to patients having a Charlson co-morbidity ≥ 3 at the time of hospital admission. SHEA/IDSA guidelines were more accurate than ESCMID criteria in predicting severe CDI in our collective, of mostly severely ill patients, in a tertiary care hospital setting.
Literatur
1.
Zurück zum Zitat McDonald LC, Banerjee S, Jernigan DB. Increasing incidence of Clostridium difficile associated disease in US acute care hospitals, 1993–2001. Presented at the 14th Annual Scientific Meeting of the Society for Healthcare Epidemiology America (NY); Apr 17–20, 2004. McDonald LC, Banerjee S, Jernigan DB. Increasing incidence of Clostridium difficile associated disease in US acute care hospitals, 1993–2001. Presented at the 14th Annual Scientific Meeting of the Society for Healthcare Epidemiology America (NY); Apr 17–20, 2004.
2.
Zurück zum Zitat Indra A, Huhulescu S, Fiedler A, Kernbichler S, Blaschitz M, Allerberger F. Outbreak of Clostridium difficile 027 infection in Vienna, Austria 2008–2009. Euro Surveill. 2009;14(17):pii = 19186. Indra A, Huhulescu S, Fiedler A, Kernbichler S, Blaschitz M, Allerberger F. Outbreak of Clostridium difficile 027 infection in Vienna, Austria 2008–2009. Euro Surveill. 2009;14(17):pii = 19186.
3.
Zurück zum Zitat Inns T, Gorton R, Berrington A, et al. Effect of ribotype on all-cause mortality following Clostridium difficile infection. J Hosp Infect. 2013;84(3):235–41. PubMedCrossRef Inns T, Gorton R, Berrington A, et al. Effect of ribotype on all-cause mortality following Clostridium difficile infection. J Hosp Infect. 2013;84(3):235–41. PubMedCrossRef
4.
Zurück zum Zitat Indra A, Huhulescu S, Schneeweis M, et al. Characterization of Clostridium difficile isolates using capillary gel electrophoresis-based PCR ribotyping. J Med Microbiol. 2008;57(11):1377–82. PubMedCentralPubMedCrossRef Indra A, Huhulescu S, Schneeweis M, et al. Characterization of Clostridium difficile isolates using capillary gel electrophoresis-based PCR ribotyping. J Med Microbiol. 2008;57(11):1377–82. PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Bauer MP, Kuijper EJ, van Dissel JT. European Society of Clinical Microbiology and Infectious Diseases. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect. 2009;15(12):1067–79. PubMedCrossRef Bauer MP, Kuijper EJ, van Dissel JT. European Society of Clinical Microbiology and Infectious Diseases. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect. 2009;15(12):1067–79. PubMedCrossRef
6.
Zurück zum Zitat Cohen SH, Gerding DN, Johnson S, et al. Society for Healthcare Epidemiology of America; Infectious Diseases Society of America. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431–55. PubMedCrossRef Cohen SH, Gerding DN, Johnson S, et al. Society for Healthcare Epidemiology of America; Infectious Diseases Society of America. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431–55. PubMedCrossRef
7.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL, Mackenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987;40(5):373–83. PubMedCrossRef Charlson ME, Pompei P, Ales KL, Mackenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987;40(5):373–83. PubMedCrossRef
8.
Zurück zum Zitat Gujja D, Friedenberg FK. Predictors of serious complications due to Clostridium difficile infection. Aliment Pharmacol Ther. 2009;29(6):635–42. PubMedCrossRef Gujja D, Friedenberg FK. Predictors of serious complications due to Clostridium difficile infection. Aliment Pharmacol Ther. 2009;29(6):635–42. PubMedCrossRef
9.
10.
Zurück zum Zitat Wenisch JM, Schmid D, Kuo HW, et al. Hospital-acquired Clostridium difficile infection: determinants for severe disease. Eur J Clin Microbiol Infect Dis. 2012;31(8):1923–30. PubMedCrossRef Wenisch JM, Schmid D, Kuo HW, et al. Hospital-acquired Clostridium difficile infection: determinants for severe disease. Eur J Clin Microbiol Infect Dis. 2012;31(8):1923–30. PubMedCrossRef
11.
Zurück zum Zitat Wenisch JM, Schmid D, Tucek G, et al. A prospective cohort study on hospital mortality due to Clostridium difficile infection. Infection. 2012;40(5):479–84. PubMedCrossRef Wenisch JM, Schmid D, Tucek G, et al. A prospective cohort study on hospital mortality due to Clostridium difficile infection. Infection. 2012;40(5):479–84. PubMedCrossRef
12.
Zurück zum Zitat Schmid D, Kuo HW, Simons E, et al. All-cause mortality in hospitalized patients with infectious diarrhea: Clostridium difficile versus other enteric pathogens in Austria from 2008 to 2010. J Infect Public Health. 2014;7:133–44. PubMedCrossRef Schmid D, Kuo HW, Simons E, et al. All-cause mortality in hospitalized patients with infectious diarrhea: Clostridium difficile versus other enteric pathogens in Austria from 2008 to 2010. J Infect Public Health. 2014;7:133–44. PubMedCrossRef
13.
Zurück zum Zitat Gomez-Simmonds A, Kubin CJ, Furuya EY. Comparison of 3 severity criteria for Clostridium difficile infection. Infect Control Hosp Epidemiol. 2014;35(2):196–9. PubMedCrossRef Gomez-Simmonds A, Kubin CJ, Furuya EY. Comparison of 3 severity criteria for Clostridium difficile infection. Infect Control Hosp Epidemiol. 2014;35(2):196–9. PubMedCrossRef
Metadaten
Titel
Severe Clostridium difficile infection: incidence and risk factors at a tertiary care university hospital in Vienna, Austria
verfasst von
MD Peter Starzengruber
MD Luigi Segagni Lusignani
PhD Thomas Wrba
MD Dieter Mitteregger
MD Alexander Indra
MD Prof. Wolfgang Graninger
MD, MBA Elisabeth Presterl
MD Magda Diab-Elschahawi
Publikationsdatum
01.07.2014
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 13-14/2014
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-014-0549-x